IP Library Granted Patent US 8,527,055
Granted Patent B2
US 8,527,055 · App. 12/508,104 · Granted Sep 3, 2013

Application of an electrical field in the vicinity of the trabecular meshwork to treat glaucoma

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,527,055
App. No.
12/508,104
Granted
Sep 3, 2013
Kind
B2
Abstract

The present invention is a method of treating glaucoma by applying an electric field in the vicinity of the juxtacanalicular region of the trabecular meshwork sufficient to cause migration or reorientation of glycosaminoglycans located in the extracellular matrix. A device for applying the electric field includes a controller coupled to a pressure sensor, and a pair of electrodes coupled to a voltage source. The electrodes apply the electric field, and the controller controls the application of the electric field based on IOP measurements from the pressure sensor.

Claims (8)

1. A method of treating glaucoma in an eye having a juxtacanalicular region of a trabecular meshwork containing an extracellular matrix, the method comprising:

applying an electric field with a strength of between 500 and 5,000 Volts per centimeter in a vicinity of the juxtacanalicular region of the trabecular meshwork to cause migration or reorientation of glycosaminoglycans located in the extracellular matrix.

2. The method of claim 1 wherein the electric field is a pulsed electric field.

3. A method of treating glaucoma comprising:

providing a pair of electrodes coupled to a voltage source, the pair of electrodes having a spacing of less than one millimeter;

placing the pair of electrodes in the vicinity of the juxtacanalicular region of a trabecular meshwork; and

applying a voltage of between 50 and 500 volts across the pair of electrodes sufficient to cause migration or reorientation of glycosaminoglycans located in the extracellular matrix.

4. The method of claim 2 wherein the voltage applied is a series of voltage pulses.

Assignments (3)
CONFIRMATORY DEED OF ASSIGNMENT EFFECTIVE APRIL 8, 2019 Recorded Jul 23, 2020
From: ALCON RESEARCH, LLC
To: ALCON INC.
Reel/Frame 053293/0484 →
MERGER Recorded Jul 21, 2020
From: ALCON RESEARCH, LTD.
To: ALCON RESEARCH, LLC
Reel/Frame 053273/0022 →
CONFIRMATORY DEED OF ASSIGNMENT EFFECTIVE APRIL 8, 2019 Recorded Dec 10, 2019
From: NOVARTIS AG
To: ALCON INC.
Reel/Frame 051454/0788 →